{"denomUnitsSelected":"Participants","description":"To compare the FN-related health-related quality of life (HRQOL) among intermediate risk participants registered to intervention components by component treatment assignment (administer PP-CSF to intermediate risk participants versus not). Assessed using the Functional Assessment of Cancer Therapy - Febrile Neutropenia (Version 4) (FACT-N). Includes FACT general cancer score and FN-related score. A linear mixed effects model will be fit to assess the effect of the intervention on HRQOL. Component-level characteristics, participant-level clinical and demographic variables will be adjusted.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to up to 14 days","title":"FN-related Health-Related Quality of Life (HRQOL) Among Intermediate Risk Participants","type":"SECONDARY"}